Salient Capital Advisors’s Microvast MVST Stock Holding History

Salient Capital Advisors’s Portfolio MVST Stock Details MVST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,529,800	Closed	-$3.4M	–	48
2022 Q2	$3.4M	Sell	1,529,800 -470,200	-24%	-$2.02M	0.18%	31
2022 Q1	$13.4M	Hold	2,000,000	–	–	0.57%	24
2021 Q4	$11.3M	Hold	2,000,000	–	–	0.57%	26
2021 Q3	$16.4M	Buy	+2,000,000	New	+$20.9M	0.84%	26

Other funds holding MVST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Salient Capital Advisors's MVST Position: Q3 2022 in Review

Salient Capital Advisors sold out of Microvast (MVST) in Q3 2022, closing a stake of 1,529,800 shares — an estimated $3.4M sold.

Salient Capital Advisors first reported a position in MVST in Q3 2021 and held it in 4 quarters. The position peaked at $16.4M in Q3 2021. 110 funds tracked by Wall St. Rank hold MVST as of Q3 2022.

Salient Capital Advisors reported no remaining Microvast position as of Q3 2022 after selling out during the quarter.
Salient Capital Advisors sold 1,529,800 Microvast shares in Q3 2022, an estimated $3.4M.
Salient Capital Advisors first reported a position in Microvast in Q3 2021 and held it in 4 quarters.
Salient Capital Advisors's Microvast position peaked at $16.4M in Q3 2021.
110 funds tracked by Wall St. Rank held Microvast as of Q3 2022.

Based on Salient Capital Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.